Neurosense Therapeutics Ltd. Financial Overview
Neurosense Therapeutics Ltd.'s market cap is currently $24.65M. The company's EPS TTM is $-0.044; its P/E ratio is -1.40; Neurosense Therapeutics Ltd. is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
